Division of Clinical Immunology and Rheumatology, Department of Medicine, San Antonio, Texas, USA.
Nutr Rev. 2012 Jan;70(1):22-40. doi: 10.1111/j.1753-4887.2011.00451.x.
Osteoporosis is a medical condition that affects millions of men and women. People with this condition have low bone mass, which places them at increased risk for bone fracture after minor trauma. The surgeries and treatments required to repair and heal bone fractures involve long recovery periods and can be expensive. Because osteoporosis occurs frequently in the elderly, the financial burden it places on society is likely to be large. In the United States, the Food and Drug Administration has approved several drugs for use in the prevention and treatment of osteoporosis. However, all of the currently available agents have severe side effects that limit their efficacy and underscore the urgent need for new treatment options. One promising approach is the development of alternative (nonpharmaceutical) strategies for bone maintenance, as well as for the prevention and treatment of osteoporosis. This review examines the currently available nonpharmaceutical alternatives that have been evaluated in in vitro and in vivo studies. Certain plants from the following families have shown the greatest benefits on bone: Alliceae, Asteraceae, Thecaceae, Fabaceae, Oleaceae, Rosaceae, Ranunculaceae, Vitaceae, Zingiberaceae. The present review discusses the most promising findings from studies of these plant families.
骨质疏松症是一种影响数以百万计的男性和女性的医学疾病。患有这种疾病的人骨量低,在受到轻微创伤后,骨折的风险增加。修复和愈合骨折所需的手术和治疗需要长时间的恢复,而且费用昂贵。由于骨质疏松症在老年人中很常见,因此它给社会带来的经济负担可能很大。在美国,食品和药物管理局已批准几种药物用于预防和治疗骨质疏松症。然而,目前所有可用的药物都有严重的副作用,限制了它们的疗效,突显了迫切需要新的治疗选择。一种有前途的方法是开发替代(非药物)的骨骼维持策略,以及预防和治疗骨质疏松症。这篇综述审查了目前已在体外和体内研究中评估的非药物替代方法。以下科的某些植物在骨骼方面显示出最大的益处:伞形科、菊科、肉座菌科、豆科、木犀科、蔷薇科、毛茛科、葡萄科、姜科。本综述讨论了这些植物科研究中最有希望的发现。